Výsledky vyhledávání

Safety and Pharmacokinetics of Hyperimmune Anti-Human Immunodeficiency Virus (HIV) Immunoglobulin Administered to HIV-Infected Pregnant Women and Their Newborns

Autor: John S. Lambert, J Jr Moye, W. A. Meyer, E. Jimenez, G. Hirsch, Lynne M. Mofenson, Edward O’neill, C. V. Sapan, E. R. Stiehm, A. Kovacs, Courtney V Fletcher, B. J. Mathieson, G. J. Nemo, L. M. Cummins, A. Stek

Publikováno v: Scopus-Elsevier

The pharmacokinetics and safety of hyperimmune anti-human immunodeficiency virus (HIV) intravenous immunoglobulin (HIVIG) were evaluated in the first 28 maternal-infant pairs enrolled in a randomized, intravenous immunoglobulin (IVIG)-controlled tria

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9baaf1fbd48adfac8ebfa07e153f7084
https://doi.org/10.1093/infdis/175.2.283

Zobrazit plný text záznamu

Donation frequency of blood donors participating in a prospective cohort study of iron status

Autor: Shrein H, Bahrami, Anne M, Guiltinan, Karen S, Schlumpf, Erik, Scott, Linda L, Banks, Pam, D'Andrea, Elizabeth L, Hartman, Vibha, Vij, David J, Wright, Bryan, Spencer, Edward L, Murphy, G J, Nemo

Publikováno v: Transfusion. 51(6)

Blood centers are interested in understanding determinants of frequent blood donation. We hypothesized that participation in uncompensated research could result in higher donation rates.Donation rates for 2425 subjects from six US blood centers enrol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e5fc5724f1ca668605cea6313c845f34
https://pubmed.ncbi.nlm.nih.gov/21658037

Zobrazit plný text záznamu

Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors

Autor: P E, Pellett, D J, Wright, E A, Engels, D V, Ablashi, S C, Dollard, B, Forghani, S A, Glynn, J J, Goedert, F J, Jenkins, T-H, Lee, F, Neipel, D S, Todd, D, Whitby, G J, Nemo, M P, Busch

Publikováno v: Transfusion. 43(9)

As part of assessing the possibility of transfusion transmission of human herpesvirus 8 (HHV-8 or Kaposi's sarcoma-associated herpesvirus), HHV-8 seroprevalence was estimated among US blood donors, the performance of HHV-8 serologic tests was compare

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::025954a2e51e266b3ca1960956651b79
https://pubmed.ncbi.nlm.nih.gov/12919429

Zobrazit plný text záznamu

Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)

Autor: E L, Murphy, S M, Bryzman, S A, Glynn, D I, Ameti, R A, Thomson, A E, Williams, C C, Nass, H E, Ownby, G B, Schreiber, F, Kong, K R, Neal, G J, Nemo

Publikováno v: Hepatology (Baltimore, Md.). 31(3)

Injection drug use (IDU) is a known risk factor for hepatitis C virus (HCV) infection, but the strength of other parenteral and sexual risk factors is unclear. In 1997, we performed a case-control study of 2,316 HCV-seropositive blood donors and 2,31

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5a64bde8e578de6be9114e7e8ce481ae
https://pubmed.ncbi.nlm.nih.gov/10706576

Zobrazit plný text záznamu

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team

Autor: L M, Mofenson, J S, Lambert, E R, Stiehm, J, Bethel, W A, Meyer, J, Whitehouse, J, Moye, P, Reichelderfer, D R, Harris, M G, Fowler, B J, Mathieson, G J, Nemo

Publikováno v: The New England journal of medicine. 341(6)

Maternal, obstetrical, and infant-related factors associated with the risk of perinatal transmission of human immunodeficiency virus type 1 (HIV-1) were identified before the widespread use of zidovudine therapy in pregnant women. The risk factors fo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::efafe52d930875174732c8a52b8468e3
https://pubmed.ncbi.nlm.nih.gov/10610439

Zobrazit plný text záznamu

Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors. Retrovirus Epidemiology Donor Study

Autor: E L, Murphy, S A, Glynn, J, Fridey, J W, Smith, R A, Sacher, C C, Nass, H E, Ownby, D J, Wright, G J, Nemo

Publikováno v: Archives of internal medicine. 159(13)

To determine whether human T-lymphotropic virus type II (HTLV-II) infection is associated with an increased incidence of bacterial infections, we prospectively observed cohorts of HTLV-I- and HTLV-II-infected and seronegative subjects in 5 US cities.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5099eaa5b069ddddf8c9a936ba4bfde0
https://pubmed.ncbi.nlm.nih.gov/10399901

Zobrazit plný text záznamu

Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group

Autor: E L, Murphy, S A, Glynn, J, Fridey, R A, Sacher, J W, Smith, D J, Wright, B, Newman, J W, Gibble, D I, Ameti, C C, Nass, G B, Schreiber, G J, Nemo

Publikováno v: The Journal of infectious diseases. 176(6)

Disease associations of human T lymphotropic virus types I and II (HTLV-I and -II) infection were studied in 154 HTLV-I-infected, 387 HTLV-II-infected, and 799 uninfected blood donors. Adjusted odds ratios (ORs) and 99% confidence intervals (CIs) wer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0937a2efa16949bf8d59abef47d9f862
https://pubmed.ncbi.nlm.nih.gov/9395356

Zobrazit plný text záznamu

Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study

Autor: A E, Williams, R A, Thomson, G B, Schreiber, K, Watanabe, J, Bethel, A, Lo, S H, Kleinman, C G, Hollingsworth, G J, Nemo

Publikováno v: JAMA. 277(12)

Individuals who do not respond accurately to questions about infectious disease risk factors at the time of blood donation represent a potential threat to the safety of the blood supply. This study was designed to estimate the prevalence of undetecte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6e75a4684c73452ff7f6970aabf5d98b
https://pubmed.ncbi.nlm.nih.gov/9228428

Zobrazit plný text záznamu

Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group

Autor: J S, Lambert, L M, Mofenson, C V, Fletcher, J, Moye, E R, Stiehm, W A, Meyer, G J, Nemo, B J, Mathieson, G, Hirsch, C V, Sapan, L M, Cummins, E, Jimenez, E, O'Neill, A, Kovacs, A, Stek

Publikováno v: The Journal of infectious diseases. 175(2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::99cee99f37f6b4f07f7191e37e8a3fbf
https://pubmed.ncbi.nlm.nih.gov/9697754

Zobrazit plný text záznamu

Demographic determinants of hepatitis C virus seroprevalence among blood donors

Autor: E L, Murphy, S, Bryzman, A E, Williams, H, Co-Chien, G B, Schreiber, H E, Ownby, R O, Gilcher, S H, Kleinman, L, Matijas, R A, Thomson, G J, Nemo

Publikováno v: JAMA. 275(13)

To measure demographic determinants of hepatitis C virus (HCV) seroprevalence among blood donors in the United States.Cross-sectional epidemiological study.Five blood centers in different regions of the United States.A total of 862,398 consecutive vo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fb6eee56a6d0f51df1c9b7d3074391cd
https://pubmed.ncbi.nlm.nih.gov/8596257

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání